Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Discover Innovation at Connect Labs Phoenix
- Julie E. Bauman, MD, MPH, Joins the College as Inaugural Chair of Interdisciplinary Oncology
- ASU a partner in new national Foundry School announced by White House
- ARIZONA COMMERCE AUTHORITY ACCEPTING APPLICATIONS FOR THE FALL 2026 ARIZONA INNOVATION CHALLENGE
- ‘A monumental day’: Inaugural class of John Shufeldt School of Medicine and Medical Engineering receive white coats
- University of Arizona and Gila River Health Care Launch Nation’s First MD-Granting Medical School Branch within a Tribal Nation
- Arizona Grants $5M to Barrow for Clinical Trial of Ibogaine in TBI